Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04830202
Title Expanded Access to Telisotuzumab Vedotin
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors AbbVie
Indications

lung non-small cell carcinoma

Therapies

Telisotuzumab vedotin

Age Groups: senior | adult
Covered Countries


No variant requirements are available.